A New Chapter for Psoriatic Arthritis: Bristol Myers Squibb's Sotyktu Wins Key FDA Approval Eli Lilly CEO Sees Medicare Support as Game-Changer for New Oral Obesity Pill The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race